Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-201P is a pseudogene derived from U6 small nuclear RNA (U6 snRNA), which is a highly conserved component of the spliceosome machinery involved in pre-mRNA splicing[1][3]. While originally considered "junk" DNA, pseudogenes like RNU6-201P are now recognized as potentially functional regulatory elements[2]. U6 snRNA pseudogenes are markers of retrotransposition dynamics and can be generated through LINE element-mediated processes[5]. The parent U6 snRNA is crucial for spliceosome function, forming the catalytic core and coordinating metal ions essential for the two-step splicing reaction[1]. U6 is the most highly conserved of all spliceosomal snRNAs across species, and vertebrate genomes contain multiple copies and pseudogenes of U6, suggesting evolutionary importance[3]. Some pseudogenes can be transcribed and processed into regulatory RNAs that influence their parent genes through mechanisms such as producing small interfering RNAs or acting as microRNA decoys[2]. However, the specific functional role of RNU6-201P itself has not been characterized in the available literature.
None applicable (pseudogene, not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA U6 small nuclear 201 pseudogene (RNU6-201P).